跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,428 条关于
“PharmAbcine/Merck”
全部
1,428
临床试验
153
药物
215
机构
61
资讯
999
去年
mTNBC Pipeline Shows Promise with Novel Therapies in Clinical Trials
去年
PharmAbcine's PMC-403 Receives Safety Approval for 4mg Single-Dose Cohort in Phase 1 AMD Trial
去年
Aprogen's PMC-309 Shows Early Anticancer Activity in Phase 1 Trial, Advances to Higher Dose Testing
4年前
Sutro Biopharma and Merck Advance Novel Cytokine Derivative into Phase 1 for Solid Tumors
去年
Merck Accelerates Subcutaneous Keytruda Launch Following Positive Phase 3 Results
3年前
Merck Launches Constitutional Challenge Against Medicare Drug Price Negotiations
2年前
Merck and Daiichi Sankyo Form $22 Billion Alliance for Three Novel Antibody-Drug Conjugates
去年
Exelixis and Merck Collaborate to Advance Zanzalintinib in Head and Neck and Renal Cell Carcinomas
8个月前
Merck Pursues Acquisition of Cancer Drug Developer Revolution Medicines
去年
Merck Explores $3+ Billion Acquisition of Swiss Biotech MoonLake Immunotherapeutics
第 1 页,共 100 页
上一页
下一页